Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01184755 · ClinicalTrials.gov registry record · NA

RCT of Effects of Device-guided Breathing on Ambulatory BP

A NA study of Hypertension, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
253
Enrollment target
2
Study locations

NCT01184755 is a NA study of Hypertension that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 253 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01184755, a NA study of Hypertension, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
253 participants
Enrollment target
2
Study locations

Study Summary

Our aim is to conduct a randomized controlled trial (RCT) to test the efficacy of a guided breathing intervention on ambulatory blood pressure (ABP), both systolic and diastolic BP. There are 3 groups: 1) Intervention group instructed to use the RESPeRate device that guides the breath into the 6 breaths/minute range daily for 8 weeks. 2) Relaxation control condition (using a modified device to guide breathing at 13 breaths/minute rate); and 3) Usual Care (UC). After the initial 8 week trial, the main outcome, the intervention group will be randomly assigned to stop using the RESPeRate device or to continue using it for 8 more weeks.

Conditions Studied

Interventions

  • BEHAVIORAL Relaxation
  • DEVICE RESPeRate

Study Locations (2)

New Jersey

  • UMDNJ - Robert Wood Johnson Medical School - New Brunswick

New York

  • Columbia University Medical Center - New York

Trial Details

FieldValue
Enrollment Target 253 participants
Start Date 2008-05
Est. Completion 2014-07
Phase NA

What the Registry Record Tells You About NCT01184755

The ClinicalTrials.gov registry entry for NCT01184755 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 253 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (93% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Relaxation is the first listed.

NCT01184755 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New Jersey, New York.

Frequently Asked Questions

What is clinical trial NCT01184755 about?

NCT01184755 is a clinical study titled "RCT of Effects of Device-guided Breathing on Ambulatory BP". Our aim is to conduct a randomized controlled trial (RCT) to test the efficacy of a guided breathing intervention on ambulatory blood pressure (ABP), both systolic and diastolic BP. There are 3 groups: 1) Intervention group instructed to use the RESPeRate device that guides the breath into the 6 bre...

What is the current status of trial NCT01184755?

This trial is currently completed. It is a NA study. The enrollment target is 253 participants. The study started on 2008-05. Estimated completion is 2014-07.

What conditions does trial NCT01184755 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT01184755?

The interventions under investigation include: Relaxation (BEHAVIORAL), RESPeRate (DEVICE).

Who is sponsoring clinical trial NCT01184755?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01184755 being conducted?

This trial has 2 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.